Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11.4 TWD
1.75 B TWD
2.52 B TWD
117.83 M
About PharmaEngine, Inc.
Sector
Industry
CEO
Hong Ren Wang
Website
Headquarters
Taipei
Founded
2002
ISIN
TW0004162003
FIGI
BBG0021164Q8
PharmaEngine, Inc. engages in the research, development and manufacture of biopharmaceutical products. It develops drug treatments for pancreatic, gastric, brain, breast, head, neck, liver, rectal and prostate cancer; soft tissue sarcoma, and solid tumor. The company was founded by Chang Ching Yeh and Jung Chin Lin on August 12, 2002 and is headquartered in Taipei, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4162 is 66.2 TWD — it has increased by 2.17% in the past 24 hours. Watch PharmaEngine, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange PharmaEngine, Inc. stocks are traded under the ticker 4162.
4162 stock has fallen by −1.79% compared to the previous week, the month change is a −1.64% fall, over the last year PharmaEngine, Inc. has showed a −21.00% decrease.
We've gathered analysts' opinions on PharmaEngine, Inc. future price: according to them, 4162 price has a max estimate of 100.00 TWD and a min estimate of 74.10 TWD. Watch 4162 chart and read a more detailed PharmaEngine, Inc. stock forecast: see what analysts think of PharmaEngine, Inc. and suggest that you do with its stocks.
4162 reached its all-time high on May 28, 2014 with the price of 246.6 TWD, and its all-time low was 33.1 TWD and was reached on Mar 23, 2020. View more price dynamics on 4162 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4162 stock is 1.22% volatile and has beta coefficient of 0.40. Track PharmaEngine, Inc. stock price on the chart and check out the list of the most volatile stocks — is PharmaEngine, Inc. there?
Today PharmaEngine, Inc. has the market capitalization of 9.25 B, it has decreased by −0.77% over the last week.
Yes, you can track PharmaEngine, Inc. financials in yearly and quarterly reports right on TradingView.
PharmaEngine, Inc. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
4162 earnings for the last quarter are 0.12 TWD per share, whereas the estimation was 0.69 TWD resulting in a −82.61% surprise. The estimated earnings for the next quarter are 0.68 TWD per share. See more details about PharmaEngine, Inc. earnings.
PharmaEngine, Inc. revenue for the last quarter amounts to 197.00 M TWD, despite the estimated figure of 224.00 M TWD. In the next quarter, revenue is expected to reach 220.00 M TWD.
4162 net income for the last quarter is 17.79 M TWD, while the quarter before that showed 102.30 M TWD of net income which accounts for −82.62% change. Track more PharmaEngine, Inc. financial stats to get the full picture.
Yes, 4162 dividends are paid annually. The last dividend per share was 6.00 TWD. As of today, Dividend Yield (TTM)% is 9.32%. Tracking PharmaEngine, Inc. dividends might help you take more informed decisions.
PharmaEngine, Inc. dividend yield was 6.64% in 2024, and payout ratio reached 49.22%. The year before the numbers were 1.42% and 78.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 19, 2025, the company has 44 employees. See our rating of the largest employees — is PharmaEngine, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PharmaEngine, Inc. EBITDA is 2.04 B TWD, and current EBITDA margin is 81.74%. See more stats in PharmaEngine, Inc. financial statements.
Like other stocks, 4162 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PharmaEngine, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PharmaEngine, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PharmaEngine, Inc. stock shows the sell signal. See more of PharmaEngine, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.